title: A phase II trial of pemetrexed and gemcitabine in patients with metastatic breast cancer who have received prior taxane therapy.
authors.affiliation: USO, Texas Oncology, Baylor Sammons Cancer Center, Dallas, TX 75246, USA. john.pippen@usoncology.com
authors.forename: John
authors.initials: J
authors.lastname: Pippen
authors.forename: Anthony D
authors.initials: AD
authors.lastname: Elias
authors.forename: Marcus
authors.initials: M
authors.lastname: Neubauer
authors.forename: Christopher
authors.initials: C
authors.lastname: Stokoe
authors.forename: LaTrice G
authors.initials: LG
authors.lastname: Vaughn
authors.forename: Yanping
authors.initials: Y
authors.lastname: Wang
authors.forename: Mauro
authors.initials: M
authors.lastname: Orlando
authors.forename: Oluwatoyin
authors.initials: O
authors.lastname: Shonukan
authors.forename: Joseph
authors.initials: J
authors.lastname: Muscato
authors.forename: Joyce A
authors.initials: JA
authors.lastname: O'Shaughnessy
authors.forename: Julie
authors.initials: J
authors.lastname: Gralow
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality; D003841:Deoxycytidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D005260:Female; D005971:Glutamates / Q000008:administration & dosage / Q000009:adverse effects; D006147:Guanine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D006801:Humans; D053208:Kaplan-Meier Estimate; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D000068437:Pemetrexed; D016879:Salvage Therapy / Q000379:methods; D043823:Taxoids / Q000627:therapeutic use; D016896:Treatment Outcome; D000093542:Gemcitabine
chemical_list: D005971:Glutamates; D043823:Taxoids; D000068437:Pemetrexed; D003841:Deoxycytidine; D006147:Guanine; D000093542:Gemcitabine